Who we are

Fuhrer Engineering AG is a privately held company founded in 1999.

Martin Fuhrer did his studies at Biel School of Engineering and Architecture and gained a degree as engineer in computer science. Today he deals mainly with the conception and realisation of client / server systems and complex web applications for professional usages.

    Download Curriculum Vitae as PDF

Martin Fuhrer

What we do

Java Software Development

We have more than 15 years of experience in the development of expert level Java software and meet the highest demands of quality, reliability, and performance.

Java Backend

Our main focus is the development of high performance server software in a networked environment using micro services and other widespread technologies.

#Spring, #JPA, #Hibernate, #Tomcat, #JBoss

Java Frontend

We have great experience in developing complex Java applications with a customized user interface and running on different operating systems.

#Swing, #JavaFX

Java Fullstack

We develop complete web applications covering the whole chain from the database through the middle tier up to the browser.

#MySQL, #JavaScript, #jQuery, #Bootstrap, #Angular

CI/CD & Team Collaboration

We are used to work as part of large, international teams with increased demands for team collaboration, version control, and continuous integration and delivery.

#Git, #IntelliJ IDEA, #Jenkins, #Docker, #Scrum, #SAFe

What we did

Some of the projects we have worked on during the past 20 years.

Where we are

Fuhrer Engineering AG

Bernstrasse 18
2555 Brügg
Switzerland

Phone

+41 32 342 7442

E-Mail

info@fuhrer.com

Telekurs iD / SIX iD

Customer:
SIX Financial Information, Zürich (CH)
Technologies:
Java, Swing
Duration:
02/2005 – 10/2019

Java Application used to display worldwide reference and market data, news, and other information based on the data universe of SIX and third party providers. Besides Bloomberg and Reuters, SIX iD is one of the leading data terminals for the display of real time reference and market data.

Swiss Fund Data

Customer:
Swiss Fund Data AG, Zürich (CH)
Technologies:
Java, Grails & Groovy, Tomcat, MySQL, HTML5, CSS, JavaScript, Bootstrap
Duration:
11/2010 – 12/2018

Web application used to manage and display fund information, official publication agency for the Swiss fund market. Consists of an administration application for the management of fund information including daily prices, legal documents, etc. and a public web site built with responsive technology, optimized to be used on phones and tablets.

OST – Order Submission Tool

Customer:
UBS AG, Zürich (CH)
Technologies:
Java, Grails & Groovy, Tomcat, MySQL, HTML5, CSS, JavaScript, Bootstrap
Duration:
08/2012 – 09/2018

Web application for professional fund managers used to process buy and sell orders in the fund and ETF business. Automatic creation and distribution of PDF forms.

GLIS – Global Information System

Customer:
SIX Payment Services, Zürich (CH)
Technologies:
Java, Grails & Groovy, Tomcat, MySQL, HTML, CSS, JavaScript
Duration:
07/2014 – 02/2018

Web application used to conceive and manage incidents in all SIX payment systems. Determines automatically which clients are affected by a given incident and informs them selectively.

IMD v.4 / v.5

Customer:
IMD Ltd., Brügg (CH)
Technologies:
Java, Swing, JavaFX, Visual C++
Duration:
09/2008 — 11/2015

Controlling software for optical inspection systems in the production of injection molding parts, e.g. PET bottles and caps. Contact-free detection of defects in form, texture, color, etc.

TSE JDR Reporting

Customer:
UBS AG, Zürich (CH) & Tokyo (JP)
Technologies:
Java, PDF
Duration:
02/2015 — 09/2019

Automatic reporting of relevant data for ETF’s traded on the Tokyo stock exchange (TSE). Automatic creation of multi-page PDF reports in Japanese language, containing up-to-the-minute market data and key figures from different sources.

SafeBase

Customer:
TheraStrat AG, Allschwil (CH)
Technologies:
Java, Swing, Apple WebObjects
Duration:
09/2001 — 02/2002

Database based expert system for the prediction of potential adverse reactions in the development of new drugs. Modeling of genetic and pharmaceutical relationships.